Donna Rennick
21Patents
8h-index
20Co-inventors
75Inventor score
Filing activity: Mar 19, 1984 → Dec 20, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5017691A | Mammalian interleukin-4 | Chemistry; Metallurgy | 151 | Expired |
| US5368854A | Use of IL-10 to treat inflammatory bowel disease | Human Necessities | 51 | Expired |
| US7090847B1 | Mammalian cytokines; related reagents and methods | Emerging Cross-Sectional Technologies | 49 | Expired |
| US7183382B2 | Mammalian genes; related reagents and methods | Emerging Cross-Sectional Technologies | 38 | Expired |
| US5096704A | Method of treating eosinophilia | Emerging Cross-Sectional Technologies | 29 | Expired |
| US4695542A | cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity | Emerging Cross-Sectional Technologies | 15 | Expired |
| US5955315A | Nucleic acids encoding human interleukin-4 | Chemistry; Metallurgy | 12 | Expired |
| US7883695B2 | IL-12P40 and IL-B30 polypeptide complex | Emerging Cross-Sectional Technologies | 9 | Active |
| US5951973A | Use of interleukin-4 (IL-4) to treat rheumatoid arthritis | Chemistry; Metallurgy | 5 | Expired |
| US7579440B2 | Mammalian cytokines; related reagents | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6676939B2 | Methods of modulating IL-174 response | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5552304A | CDNA Clones coding for human protein exhibiting a broad cellular activity spectrum (human interleukin-4) | Chemistry; Metallurgy | 2 | Expired |
| US7148330B2 | Binding compounds for IL-27 | Emerging Cross-Sectional Technologies | 2 | Expired |
| US8691953B2 | Binding compounds for IL-27 | Emerging Cross-Sectional Technologies | 1 | Active |
| US7906622B2 | IL-D80 polypeptides and IL-27 | Emerging Cross-Sectional Technologies | 0 | Active |
| US7357924B2 | Uses of IL-174 for treating helminth infections | Emerging Cross-Sectional Technologies | 0 | Expired |
| US8080392B2 | IL-D80 polynucleotides | Emerging Cross-Sectional Technologies | 0 | Active |
| US5656266A | Method of using interleukin-4 | Chemistry; Metallurgy | 0 | Expired |
| US6395268B1 | Lymphotactin uses | Chemistry; Metallurgy | 0 | Expired |
| US5807996A | Fused polypeptides comprising interleukin-4 polypeptide fragments | Chemistry; Metallurgy | 0 | Expired |
| US5730970A | Pharmaceutical compositions comprising human interleukin-4 (IL-4) | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.